A first-in-human clinical trial at UPMC shows it is feasible and safe to train the immune system to accept a transplanted ...
An international research team with the participation of researchers from the University Medical Center Göttingen (UMG), ...
Updated clinical practice guidelines on the use of vaccines to prevent seasonal COVID-19, influenza, and respiratory ...
Tumor reponse, biomarker, and subgroup analyses from the VIRAGE Phase 2b clinical trial support a VCN-01 immune-mediated mode of action and ...
MedPage Today on MSN
FDA Approves Sparsentan as First FSGS Treatment
Expanded indication supported by mixed bag of trial data ...
Researchers at the University of Pittsburgh gave transplant recipients certain immune cells from their organ donors. It ...
Cantargia AB (Publ) (Nasdaq Stockholm:CANTA) today reported that the rationale and study design of the phase 1b/2 clinical trial investigating nadunolimab in combination with immune-checkpoint ...
The US Food and Drug Administration has granted full approval to Sparsentan for the treatment of Focal Segmental ...
UPMC and University of Pittsburgh clinician-scientists have weaned and kept multiple liver transplantation patients off of ...
Scientists have taken a major step toward stopping Epstein-Barr virus (EBV), an extremely common infection linked to cancer ...
Recommendations for the diagnosis and management of severe acquired aplastic anemia are presented in a clinical practice ...
Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results